2023 International Congress » Parkinsonism, Atypical: MSA

A multimodal approach for diagnosis of early Multiple System Atrophy (MSA)

D. Claassen, J. Iregui, P. Trujillo, A. Wynn, C. Wong, M. Bradbury, D. Stamler (Nashville, USA)

Acute laryngeal stridor in the emergency department: pandemic or additional sign?

F. Gomes, C. Silva, D. Damas, I. Carvalho, I. Cunha, A. Brás, A. Morgadinho, F. Moreira (Coimbra, Portugal)

An atypical presentation of Multiple System Atrophy (MSA)

M. Magriço, V. Ferreira, B. Meira, R. Barbosa, P. Bugalho (Lisboa, Portugal)

An in-vivo study of regional synaptic density loss in patients with Multiple System Atrophy using [11C]UCB-J PET molecular imaging.

E. de Natale, A. Terry, H. Wilson, J. Verghese, G. Pagano, P. Khosropanah, M. Howard, H. Wright, L. Cashmore, L. Passamonti, M. Hutchison, K. Evans, Y. Lewis, E. Rabiner, M. Politis (London, United Kingdom)

Analysis of the therapeutic potential of c-Abl inhibition in Multiple System Atrophy

M. Werner, E. Bertin, A. Simmonet, E. Noé, P. Fernagut, J. Molina, K. Lowe, E. Bezard, J. Kordower (Atlanta, USA)

Atypical parkinsonism syndromes: clinical presentations

A. Gunduz, S. Akkus, FZ. Calikusu, E. Koçhan Kızılkılıç, B. Poyraz, A. Altunç, G. Kızıltan (Istanbul, Turkey)

Autonomic dysfunction in the early stages of atypical Parkinsonism would have the first approach in the diagnosis: A report of fifteen cases in the Mexican population.

DAN. Rebolledo Garcia, XEL. Dominguez Vega, MAR. Briseño Godinez, CAR. Quintero Flores (Mexico, Mexico)

Blood NfL can track progression in multiple system atrophy

V. Chelban, A. Perez-Soriano, C. Wilke, A. Foubert-Samier, N. Vijiaratnam, T. Guo, E. Jabbari, K. Senkevich, B. Laurens, P. Péran, O. Rascol, L. Schöls, C. Kobylecki, M. Hu, J. Rowe, T. Foltynie, N. Wood, A. Heslegrave, H. Zetterberg, M. Bocchetta, J. Rohrer, M. Marti, M. Synofzik, H. Morris, W. Meissner, H. Houlden (London, United Kingdom)

Blood Pressure Monitoring in Multiple System Atrophy: Focused on Nocturnal Dipping Pattern

I. Jeremia, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

Brain metabolism associated with clinical feature in patients with multiple system atrophy

S. Lee, S. Jo, J. Lee, S. Chung (Seoul, Republic of Korea)

Clinical and radiological characteristics of a cohort of seventy-one Multiple System Atrophy patients

G. Franco, G. Lazzeri, E. Bernardi, F. Arienti, A. Di Fonzo (Milan, Italy)

Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty

L. Chougar, A. Faucher, J. Faouzi, FX. Lejeune, F. Cormier, M. Vidailhet, O. Colliot, S. Lehericy, D. Grabli, B. Degos (PARIS, France)

Data-driven subtypes of multiple system atrophy and the implication on prognosis

C-C. Fan, C. Han, X-M. Wang, W. Mao, E-H. Xu, P. Chan, S-Y. Liu (Beijing, China)

Disease progression in multiple system atrophy: the value of clinical cohorts with long follow-up

T. Saulnier, M. Fabbri, A. Pavy-Le Traon, M. Le Goff, C. Helmer, P. Péran, WG. Meissner, O. Rascol, C. Proust-Lima, A. Foubert-Samier (Bordeaux, France)

Evaluation of structural brain stem measurements for the differential diagnosis of MSA and IPD

M. Loffeld, S. Kannenberg, A. Hausmann, C. Hartmann, J. Caspers, C. Rubbert, A. Schnitzler (Düsseldorf, Germany)

Exosomal α-synuclein in Multiple system atrophy and parkinson’s disease cause distinct synucleinopathies

X. Chi, L. Kou, Y. Sun, Y. Xia, T. Wang (Wuhan, China)

Expression profile of circRNA in peripheral blood mononuclear cells of patients with Parkinson’s disease and atypical parkinsonian syndromes

S. Ravanidis, A. Bougea, A. Simistiras, M. Maniati, C. Koros, A. Simitsi, L. Stefanis, E. Doxakis (Athens, Greece)

Gender-specific differences of gait in parkinsonian syndromes

V. Sidoroff, F. Jagusch, P. Bachmann, N. Roth, N. Hergenröder-Lenzner, I. Teckenburg, A. Ibrahim, S. Büchner, D. Benninger, K. Seppi, F. Krismer, B. Eskofier, J. Winkler, J. Klucken, K. Aminian, H. Gassner, G. Wenning, C. Raccagni (Innsbruck, Austria)

In vivo proteomic investigation of deeply phenotyped parkinsonian syndromes for biomarkers of differential diagnosis

S. Katzdobler, A. Bernhardt, G. Nübling, C. Palleis, U. Fietzek, E. Weidinger, M. Brendel, G. Höglinger, J. Levin (Munich, Germany)

Investigation of usefulness of new MSA diagnostic criteria

M. Tarisawa, M. Matsushima, A. Kudo, K. Sakushima, Y. Kanatani, N. Nishimoto, J. Sawada, T. Matsuoka, S. Hisahara, H. Uesugi, N. Minami, K. Sako, A. Takei, A. Tamakoshi, N. Sato, H. Sasaki, I. Yabe (Sapporo, Japan)

Laryngeal clinical biomarkers in atypical Parkinsonism – results from an international multicenter study

F. Gandor, A. Vogel, L. Berger, D. Gruber, I. Claus, P. Corelli, G. Giannini, N. Madetko-Alster, G. Höglinger, M. Klietz, C. Schrader, B. Falkenburger, T. Shimohata, K. Kunieda, J. Kassubek, R. Kassubek, MJ. Marti, G. Wenning, A. Fanciulli, C. Pototschnig, T. Gurevich, Y. Manor, HJ. Kim, D. Weise, P. Urban, R. Dziewas, T. Warnecke (Beelitz-Heilstätten, Germany)

LRRK2 G2019S mutation in Multiple System Atrophy, a case report

T. Carrer, G. Bonato, M. Sandre, A. Emmi, A. Antonini (Padova, Italy)

Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study

N. Del Campo, P. Péran, P. Payoux, V. Rousseau, A. Drif, H. Catalá, C. Thalamas, C. Tranchant, F. Duriff, A. Marques, JP. Azulay, C. Moreau, JC. Corvol, S. Thobois, AG. Corbille, S. Frismand, B. Patterson, A. Foubert-Samier, A. Pavy-Letraon, M. Fabbri, W. Meissner, O. Rascol (Toulouse, France)

Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy

MC. Kuo, SP. Lin, RM. Wu (Taipei, Taiwan)

Pain in people with multiple system atrophy

N. Campese, B. Calio´, F. Leys, L. Kaltenbach, G. Göbel, J. Wanschitz, A. Schlager, L. Zamarian, K. Bannister, R. Chaudhuri, A. Schrag, R. Granata, S. Kiechl, W. Poewe, K. Seppi, G. Wenning, A. Fanciulli (Innsbruck, Austria)

Preliminary evidence for evolution of myoinositol and N-acteylaspartate as biomarkers of disease severity in early-stage multiple system atrophy

P. Trujillo, J. Iregui, K. Hett, A. Wynn, M. Donahue, C. Wong, D. Stamler, D. Claassen (Nashville, USA)

Prevalence of multiple system atrophy in Europe: literature review

S. Kaplan (Netanya, Israel)

Short-term effect of continuous positive airway pressure in MSA patients with sleep disordered breathing

G. Lazzeri, M. Houot, M. Patout, F. Cormier, M. Vidailhet, JC. Corvol, I. Arnulf, D. Grabli, P. Dodet (Milan, Italy)

The diagnostic utility of the new MDS criteria for multiple system atrophy: a retrospective autopsy cohort study

H. Sekiya, S. Koga, A. Murakami, M. Kawazoe, N. Martin, R. Uitti, W. Cheshire, Z. Wszolek, D. Dickson (Jacksonville, USA)

The pivotal difference in gut microbiota between multiple system atrophy and Parkinson’s disease

SY. Cheng, MC. Kuo, YF. Tseng (Taipei, Taiwan)

The pivotal role of dual tracer (FDG + DOPA) PET MRI brain for diagnosis of MSA-C.

A. Mishra, D. Chaudhari (New Delhi, India)

Therapy-associated risk decision making in individuals with multiple system atrophy and Parkinson’s disease, THE YAMSA TRIAL

A. Bernhardt, M. Oeller, I. Friedrich, E. Kocakavuk, E. Nachman, K. Peikert, M. Roderigo, A. Rossmann, T. Schröter, LO. Wilhelm, F. Gandor, J. Levin, A. Giese, A. Janzen, WH. Oertel (Munich, Germany)

UMSARS versus laryngoscopy-based assessment of dysphagia

N. El Fassi, A. Pavy-Le-Traon, E. Mouchon, O. Rascol, W. Meissner, A. Foubert-Saumier, Y. Gallois, S. Tessier, F. Ory-Magne, V. Woizard, M. Fabbri (Toulouse, France)

Use of levodopa-carbidopa intestinal gel to treat a patient with multiple system atrophy (MSA)

A. Ferreira, S. Marques, A. Vieira, M. Coelho, G. Carneiro, M. Rodrigues (Braga, Portugal)